Upregulating CD4+CD25+FOXP3+ Regulatory T Cells in Pancreatic Lymph Nodes in Diabetic NOD Mice by Adjuvant Immunotherapy

Background. Immunotherapy with Complete Freund’s adjuvant (CFA) is effective in ameliorating autoimmunity in diabetic nonobese diabetic (NOD) mice. We investigated whether CFA treatment up-regulates CD4+CD25+Foxp3+ regulatory T cells and increases transforming growth factor (TGF)-&bgr;1 production in diabetic NOD mice. Methods. New-onset diabetic NOD mice were treated with CFA and exendin-4, a potent analog of glucagon-like peptide-1. Reversal of diabetes was determined by monitoring blood glucose level. Ameliorating autoimmunity through immunoregulation was assessed by adoptive transfer. Regulatory T cells in the peripheral blood, spleen, thymus, and pancreatic nodes were measured. TGF-&bgr;1 in plasma and the insulin content in the pancreas were also measured. Immunostainings for insulin and BrdU were performed. Results. New-onset diabetes could be reversed in 38% of NOD mice treated with CFA alone and in 86% of NOD mice treated with both CFA and exendin-4. Diabetes adoptive transfer by splenocytes from CFA-treated NOD mice was delayed. The percentage of CD4+CD25+Foxp3+ regulatory T cells in the pancreatic lymph nodes of CFA-treated NOD mice was significantly increased at 1, 5, and 15 to 17 weeks after treatment. TGF-&bgr;1 in the plasma of CFA-treated NOD mice was also significantly increased. Combining CFA with exendin-4 treatment significantly increased the insulin content and the numbers of insulin and BrdU double-labeled &bgr; cells in the islets. Conclusions. Our results demonstrated that CFA treatment ameliorates autoimmunity in diabetic NOD mice by up-regulating CD4+CD25+Foxp3+ regulatory T cells and increasing TGF-&bgr;1 production. Exendin-4 enhanced the effect of CFA on reversing diabetes in NOD mice by stimulating &bgr;-cell replication.

[1]  D. Drucker,et al.  Exendin-4 modulates diabetes onset in nonobese diabetic mice. , 2008, Endocrinology.

[2]  M. Atkinson,et al.  No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes , 2007, Diabetes.

[3]  A. Cooke,et al.  Patients With Chronic Pancreatitis Have Islet Progenitor Cells in Their Ducts, but Reversal of Overt Diabetes in NOD Mice by Anti-CD3 Shows No Evidence for Islet Regeneration , 2007, Diabetes.

[4]  J. Kushner,et al.  Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes , 2006, Diabetes.

[5]  A. Cooke,et al.  Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[6]  L. Wen,et al.  TGF-β signaling is required for the function of insulin-reactive T regulatory cells , 2006 .

[7]  Y. Wan,et al.  Transforming growth factor-β: Recent advances on its role in immune tolerance , 2006 .

[8]  E. Unanue,et al.  Immunological Reversal of Autoimmune Diabetes Without Hematopoietic Replacement of ß Cells , 2006, Science.

[9]  J. Gaglia,et al.  Islet Recovery and Reversal of Murine Type 1 Diabetes in the Absence of Any Infused Spleen Cell Contribution , 2006, Science.

[10]  A. Kuznetsov,et al.  Reversal of Diabetes in Non-Obese Diabetic Mice Without Spleen Cell-Derived ß Cell Regeneration , 2006, Science.

[11]  Y. Wan,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[12]  C. Benoist,et al.  Where CD4+CD25+ T reg cells impinge on autoimmune diabetes , 2005, The Journal of experimental medicine.

[13]  Dolca Thomas,et al.  Systemic Transforming Growth Factor-&bgr;1 Gene Therapy Induces Foxp3+ Regulatory Cells, Restores Self-Tolerance, and Facilitates Regeneration Of Beta Cell Function in Overtly Diabetic Nonobese Diabetic Mice , 2005, Transplantation.

[14]  S. Sakaguchi,et al.  Regulatory T Cells in Immunologic Self-Tolerance and Autoimmune Disease , 2005, International reviews of immunology.

[15]  Bhagirath Singh,et al.  In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-γ/TNF-α , 2004 .

[16]  J. Habener,et al.  Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. , 2004, Diabetes.

[17]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[18]  D. Drucker,et al.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. , 2004, Endocrinology.

[19]  R. Flavell,et al.  TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Tan,et al.  Regulation of Autoimmune Diabetes by Complete Freund’s Adjuvant Is Mediated by NK Cells , 2004, The Journal of Immunology.

[21]  R. Flavell,et al.  CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β–TGF-β receptor interactions in type 1 diabetes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Bluestone,et al.  TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.

[23]  D. Drucker,et al.  Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. , 2003, Diabetes.

[24]  O. Kanagawa,et al.  Regulation of Diabetes Development by Regulatory T Cells in Pancreatic Islet Antigen-Specific TCR Transgenic Nonobese Diabetic Mice1 , 2002, The Journal of Immunology.

[25]  B. Portha,et al.  Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. , 2001, Diabetes.

[26]  C. Wright,et al.  Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. , 2001, Diabetes.

[27]  S. Bonner-Weir.  beta-cell turnover: its assessment and implications. , 2001, Diabetes.

[28]  Jie Zhou,et al.  Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats. , 2000, Endocrinology.

[29]  S. Bonner-Weir.  Islet growth and development in the adult. , 2000, Journal of molecular endocrinology.

[30]  S. Bonner-Weir,et al.  Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. , 1999, Diabetes.

[31]  G. Warnock,et al.  Prevention of Recurrence of IDDM in Islet-Transplanted Diabetic NOD Mice by Adjuvant Immunotherapy , 1992, Diabetes.

[32]  S. Pek,et al.  Prevention of Insulitis and Diabetes Onset by Treatment With Complete Freund's Adjuvant in NOD Mice , 1991, Diabetes.

[33]  M. Sadelain,et al.  Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. , 1990, Journal of autoimmunity.

[34]  M. Sadelain,et al.  Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy , 1990, Diabetes.

[35]  J. Kushner,et al.  Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. , 2006, Diabetes.

[36]  L. Wen,et al.  TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. , 2006, The Journal of clinical investigation.

[37]  T. Nomura,et al.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. , 2006, Current topics in microbiology and immunology.

[38]  Y. Wan,et al.  Transforming growth factor-beta: recent advances on its role in immune tolerance. , 2006, Current rheumatology reports.

[39]  Pau Serra,et al.  Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice , 2006, Nature Immunology.

[40]  Yuval Dor,et al.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. , 2004, Nature.

[41]  Bhagirath Singh,et al.  In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha. , 2004, International immunology.

[42]  R. Flavell,et al.  CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Drucker,et al.  Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1 , 2002, Treatments in endocrinology.

[44]  E. Shevach.  Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.